Literature DB >> 10551884

A catalytically active Jak2 is required for the angiotensin II-dependent activation of Fyn.

P P Sayeski1, M S Ali, A Safavi, M Lyles, S O Kim, S J Frank, K E Bernstein.   

Abstract

Recent work with interleukins has shown a convergence of tyrosine phosphorylation signal transduction cascades at the level of the Janus and Src families of tyrosine kinases. Here we demonstrate that activation of the seven-transmembrane AT(1) receptor by angiotensin II induces a physical association between Jak2 and Fyn, in vivo. This association requires the catalytic activity of Jak2 but not Fyn. Deletion studies indicate that the region of Jak2 that binds Fyn is located between amino acids 1 and 240. Studies of the Fyn SH2 and SH3 domains demonstrate that the SH2 domain plays the primary role in Jak2/Fyn association. Not surprisingly, this domain shows a marked preference for tyrosine-phosphorylated Jak2. Surface plasmon resonance estimated the dissociation equilibrium constant (K(d)) of this association to be 2.36 nM. Last, in vivo studies in vascular smooth muscle cells show that, in response to angiotensin II, Jak2 activation is required for Fyn activation and induction of the c-fos gene. The significance of these data is that Jak2, in addition to serving as a critical angiotensin II activated signal transduction kinase, also functions as a docking protein and participates in the activation of Fyn by providing phosphotyrosine residues that bind the SH2 domain of Fyn.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551884     DOI: 10.1074/jbc.274.46.33131

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  The role of Ca2+ mobilization and heterotrimeric G protein activation in mediating tyrosine phosphorylation signaling patterns in vascular smooth muscle cells.

Authors:  P P Sayeski; M S Ali; K E Bernstein
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic mice.

Authors:  Tomomi Kiyota; Satoshi Okuyama; Russell J Swan; Michael T Jacobsen; Howard E Gendelman; Tsuneya Ikezu
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

3.  Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in a Setting of Autophagy Insufficiency.

Authors:  Qingyun Qin; Chen Qu; Ting Niu; Huimei Zang; Lei Qi; Linmao Lyu; Xuejun Wang; Mitzi Nagarkatti; Prakash Nagarkatti; Joseph S Janicki; Xing Li Wang; Taixing Cui
Journal:  Hypertension       Date:  2015-11-16       Impact factor: 10.190

Review 4.  JAK out of the Box; The Rationale behind Janus Kinase Inhibitors in the COVID-19 setting, and their potential in obese and diabetic populations.

Authors:  Rahma Menshawey; Esraa Menshawey; Ayman H K Alserr; Antoine Fakhry Abdelmassih
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-10-15

Review 5.  JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation.

Authors:  Ryousuke Satou; Romer A Gonzalez-Villalobos
Journal:  JAKSTAT       Date:  2012-10-01

6.  Mutation of glutamic acid residue 1046 abolishes Jak2 tyrosine kinase activity.

Authors:  Dannielle VonDerLinden; Xianyue Ma; Eric M Sandberg; Kim Gernert; Kenneth E Bernstein; Peter P Sayeski
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.842

7.  A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis.

Authors:  Kristine L Stump; Lily D Lu; Pawel Dobrzanski; Cynthia Serdikoff; Diane E Gingrich; Ben J Dugan; Thelma S Angeles; Mark S Albom; Mark A Ator; Bruce D Dorsey; Bruce A Ruggeri; Matthew M Seavey
Journal:  Arthritis Res Ther       Date:  2011-04-21       Impact factor: 5.156

Review 8.  Redox regulation of Janus kinase: The elephant in the room.

Authors:  Roy J Duhé
Journal:  JAKSTAT       Date:  2013-08-19

9.  Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress.

Authors:  Andrey Kazakov; Rabea A Hall; Christian Werner; Timo Meier; André Trouvain; Svetlana Rodionycheva; Alexander Nickel; Frank Lammert; Christoph Maack; Michael Böhm; Ulrich Laufs
Journal:  Basic Res Cardiol       Date:  2018-09-06       Impact factor: 17.165

10.  Jak2 tyrosine kinase residues glutamic acid 1024 and arginine 1113 form a hydrogen bond interaction that is essential for Jak-STAT signal transduction.

Authors:  Eric M Sandberg; Dannielle VonDerLinden; David A Ostrov; Peter P Sayeski
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.